Evidence map›Paper›PMID 28331198›Full record

ArticleScientific reports2017

Remote control of glucose homeostasis in vivo using photopharmacology.

Zenobia B Mehta, Natalie R Johnston, Marie-Sophie Nguyen-Tu, Johannes Broichhagen, Peter Schultz, Dean P Larner, Isabelle Leclerc, Dirk Trauner, Guy A Rutter, David J Hodson

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Smart photopharmacological agents: LaVONanoscale advances · 2024
    Article
  6. Fine-tuned photochromic sulfonylureas for optical control of beta cell CaDiabetic medicine : a journal of the British Diabetic Association · 2023
    Article
  7. Review
  8. Molecular photoswitches in aqueous environments.Chemical Society reviews · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Photopharmacology.Indian journal of pharmacology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zenobia B MehtaSection of Cell Biology and Functional Genomics, Department of Medicine, Imperial College London, London, W12 0NN, UK.ORCID 0000-0002-1461-5319
Natalie R JohnstonSection of Cell Biology and Functional Genomics, Department of Medicine, Imperial College London, London, W12 0NN, UK.
Marie-Sophie Nguyen-TuSection of Cell Biology and Functional Genomics, Department of Medicine, Imperial College London, London, W12 0NN, UK.
Johannes BroichhagenDepartment of Chemistry and Center for Integrated Protein Science, LMU Munich, Munich, Germany.ORCID 0000-0003-3084-6595
Peter SchultzDepartment of Chemistry and Center for Integrated Protein Science, LMU Munich, Munich, Germany.
Dean P LarnerInstitute of Metabolism and Systems Research (IMSR) and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Edgbaston, B15 2TT, UK.
Isabelle LeclercSection of Cell Biology and Functional Genomics, Department of Medicine, Imperial College London, London, W12 0NN, UK.
Dirk TraunerDepartment of Chemistry and Center for Integrated Protein Science, LMU Munich, Munich, Germany. d.trauner@lmu.de.
Guy A RutterSection of Cell Biology and Functional Genomics, Department of Medicine, Imperial College London, London, W12 0NN, UK. g.rutter@imperial.ac.uk.ORCID 0000-0001-6360-0343
David J HodsonInstitute of Metabolism and Systems Research (IMSR) and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Edgbaston, B15 2TT, UK. d.hodson@bham.ac.uk.

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council MR/K001981/1Medical Research Council MR/N00275X/1Wellcome Trust
6 · The paper itself

Abstract

Photopharmacology describes the use of light to precisely deliver drug activity in space and time. Such approaches promise to improve drug specificity by reducing off-target effects. As a proof-of-concept, we have subjected the fourth generation photoswitchable sulfonylurea JB253 to comprehensive toxicology assessment, including mutagenicity and maximum/repeated tolerated dose studies, as well as in vivo testing in rodents. Here, we show that JB253 is well-tolerated with minimal mutagenicity and can be used to optically-control glucose homeostasis in anesthetized mice following delivery of blue light to the pancreas. These studies provide the first demonstration that photopharmacology may one day be applicable to the light-guided treatment of type 2 diabetes and other metabolic disease states in vivo in humans.

Indexed as

AnimalsBlood GlucoseDiabetes MellitusDrug-Related Side Effects and Adverse ReactionsHomeostasisHypoglycemic AgentsMicePhotosensitizing AgentsSulfonylurea CompoundsTreatment OutcomeBlood GlucoseHypoglycemic AgentsPhotosensitizing AgentsSulfonylurea Compounds

Identifiers

PMID28331198
PMCPMC5428208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.